The Screening of Antiphospholipid Antibodies in Obstetric Antiphospholipid Syndrome-Like Events: A Regional Perspective
Objective: Obstetric antiphospholipid antibody syndrome is clinically recognized by adverse obstetric outcomes. To determine which antibody level best corresponds to the risk of these clinical outcomes is difficult. Obstetric antiphospholipid antibody syndrome-like adverse obstetric outcomes with s...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Medical Network
2020-12-01
|
| Series: | Gynecology Obstetrics & Reproductive Medicine |
| Subjects: | |
| Online Access: | https://gorm.com.tr/index.php/GORM/article/view/905 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823857403156758528 |
|---|---|
| author | Onder Onen Fusun Gulizar Varol |
| author_facet | Onder Onen Fusun Gulizar Varol |
| author_sort | Onder Onen |
| collection | DOAJ |
| description |
Objective: Obstetric antiphospholipid antibody syndrome is clinically recognized by adverse obstetric outcomes. To determine which antibody level best corresponds to the risk of these clinical outcomes is difficult. Obstetric antiphospholipid antibody syndrome-like adverse obstetric outcomes with single (n=108) and repeat (n=79) documented antiphospholipid antibody titers were evaluated.
Study Design: Serum samples of 108 Obstetric antiphospholipid antibody syndrome cases and 50 healthy gestational matched controls with no history of thrombosis and congenital anomalies were subjected to testing for antiphospholipid antibodies with ELISA after the events. Of this obstetric antiphospholipid antibody syndrome group, only 79 cases underwent repeat testing within 12 weeks. Quantitative data were described by values and percentages at the levels of (>10) and (>40 U).
Results: By one documented antiphospholipid test, the mean values of anticardiolipin, and anti-β2 glycoprotein1 (aβ2GP1) of obstetric antiphospholipid antibody syndrome versus controls were significantly different (p<0.001). Of 79 women who came for repeat sampling, a total number of women with persistent antiphospholipid antibody positivity was only 43 (54.43%). The number of obstetric antiphospholipid antibody syndrome cases with >40 U of antiphospholipid antibody was only 8 (18.60%).
Conclusion: Not all obstetric antiphospholipid antibody syndrome associated pregnancy morbidities may own high (>40U) antiphospholipid antibody titers, but low antiphospholipid antibodies (>10U) also accompany to this clinical picture. Obstetric antiphospholipid antibody syndrome should always be taken into account clinically prior to laboratory findings. Besides, long persistence of antiphospholipid-M positivity in these placenta-mediated disorders may make sense in terms of trophoblastic damage.
|
| format | Article |
| id | doaj-art-1bc5d2babd8840bc9a72f9a16d4e4deb |
| institution | Kabale University |
| issn | 1300-4751 2602-4918 |
| language | English |
| publishDate | 2020-12-01 |
| publisher | Medical Network |
| record_format | Article |
| series | Gynecology Obstetrics & Reproductive Medicine |
| spelling | doaj-art-1bc5d2babd8840bc9a72f9a16d4e4deb2025-02-11T21:10:50ZengMedical NetworkGynecology Obstetrics & Reproductive Medicine1300-47512602-49182020-12-0126310.21613/GORM.2018.905The Screening of Antiphospholipid Antibodies in Obstetric Antiphospholipid Syndrome-Like Events: A Regional PerspectiveOnder Onen0Fusun Gulizar Varol1Trakya University Department of Obstetrics and GynecologyTrakya University Department of Obstetrics and Gynecology, Division of Perinatology Objective: Obstetric antiphospholipid antibody syndrome is clinically recognized by adverse obstetric outcomes. To determine which antibody level best corresponds to the risk of these clinical outcomes is difficult. Obstetric antiphospholipid antibody syndrome-like adverse obstetric outcomes with single (n=108) and repeat (n=79) documented antiphospholipid antibody titers were evaluated. Study Design: Serum samples of 108 Obstetric antiphospholipid antibody syndrome cases and 50 healthy gestational matched controls with no history of thrombosis and congenital anomalies were subjected to testing for antiphospholipid antibodies with ELISA after the events. Of this obstetric antiphospholipid antibody syndrome group, only 79 cases underwent repeat testing within 12 weeks. Quantitative data were described by values and percentages at the levels of (>10) and (>40 U). Results: By one documented antiphospholipid test, the mean values of anticardiolipin, and anti-β2 glycoprotein1 (aβ2GP1) of obstetric antiphospholipid antibody syndrome versus controls were significantly different (p<0.001). Of 79 women who came for repeat sampling, a total number of women with persistent antiphospholipid antibody positivity was only 43 (54.43%). The number of obstetric antiphospholipid antibody syndrome cases with >40 U of antiphospholipid antibody was only 8 (18.60%). Conclusion: Not all obstetric antiphospholipid antibody syndrome associated pregnancy morbidities may own high (>40U) antiphospholipid antibody titers, but low antiphospholipid antibodies (>10U) also accompany to this clinical picture. Obstetric antiphospholipid antibody syndrome should always be taken into account clinically prior to laboratory findings. Besides, long persistence of antiphospholipid-M positivity in these placenta-mediated disorders may make sense in terms of trophoblastic damage. https://gorm.com.tr/index.php/GORM/article/view/905Antiphospholipid antibodyIgM positivityObstetric antiphospholipid antibody syndrome |
| spellingShingle | Onder Onen Fusun Gulizar Varol The Screening of Antiphospholipid Antibodies in Obstetric Antiphospholipid Syndrome-Like Events: A Regional Perspective Gynecology Obstetrics & Reproductive Medicine Antiphospholipid antibody IgM positivity Obstetric antiphospholipid antibody syndrome |
| title | The Screening of Antiphospholipid Antibodies in Obstetric Antiphospholipid Syndrome-Like Events: A Regional Perspective |
| title_full | The Screening of Antiphospholipid Antibodies in Obstetric Antiphospholipid Syndrome-Like Events: A Regional Perspective |
| title_fullStr | The Screening of Antiphospholipid Antibodies in Obstetric Antiphospholipid Syndrome-Like Events: A Regional Perspective |
| title_full_unstemmed | The Screening of Antiphospholipid Antibodies in Obstetric Antiphospholipid Syndrome-Like Events: A Regional Perspective |
| title_short | The Screening of Antiphospholipid Antibodies in Obstetric Antiphospholipid Syndrome-Like Events: A Regional Perspective |
| title_sort | screening of antiphospholipid antibodies in obstetric antiphospholipid syndrome like events a regional perspective |
| topic | Antiphospholipid antibody IgM positivity Obstetric antiphospholipid antibody syndrome |
| url | https://gorm.com.tr/index.php/GORM/article/view/905 |
| work_keys_str_mv | AT onderonen thescreeningofantiphospholipidantibodiesinobstetricantiphospholipidsyndromelikeeventsaregionalperspective AT fusungulizarvarol thescreeningofantiphospholipidantibodiesinobstetricantiphospholipidsyndromelikeeventsaregionalperspective AT onderonen screeningofantiphospholipidantibodiesinobstetricantiphospholipidsyndromelikeeventsaregionalperspective AT fusungulizarvarol screeningofantiphospholipidantibodiesinobstetricantiphospholipidsyndromelikeeventsaregionalperspective |